This research presents a programmable RNA-responsive system for biosensing, diagnostics, and therapeutics using CRISPR technology, implying significant advancements in smart materials.
With the rapid expansion of RNA biology and associated biotechnologies, smart materials with programmable RNA responsiveness offer immense opportunities for biosensing, diagnostics, and therapeutics. Here, we present a programmable RNA-responsive protein material system leveraging CRISPR-Cas7–11, an RNA-guided protease complex. By immobilizing the protease complex and cleavable payload proteins onto protein scaffolds via SpyTag/SpyCatcher chemistry, we developed two platforms: (1) synthetic spider-silk fibers and (2) protein hydrogels. These materials enable sequence-specific RNA detection, triggering the controlled release of payloads such as GFP or the biofilm-degrading enzyme PslG. Applications demonstrated include viral RNA sensing and Pseudomonas aeruginosa detection with targeted biofilm degradation.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: